Literature DB >> 33528371

mHealth-Supported Delivery of an Evidence-Based Family Home-Visiting Intervention in Sierra Leone: Protocol for a Pilot Randomized Controlled Trial.

Alethea Desrosiers1, Carolyn Schafer1, Rebecca Esliker2, Musu Jambai3, Theresa Betancourt1.   

Abstract

BACKGROUND: Past trauma and exposure to violence have been related to poor emotion regulation and household violence, which can have persistent mental health effects across generations. The Family Strengthening Intervention for Early Childhood Development (FSI-ECD/called Sugira Muryango in Rwanda) is an evidence-based behavioral home-visiting intervention to promote caregiver mental health, positive parenting practices, and early childhood development among families facing adversity. In Sierra Leone and other lower- and middle-income countries, mobile health (mHealth) technology has the potential to improve health care delivery and health outcomes.
OBJECTIVE: This study aims to (1) apply a user-centered design to develop and test mHealth tools to improve supervision and fidelity monitoring of community health workers (CHWs) delivering the FSI-ECD and (2) conduct a pilot randomized controlled trial of the FSI-ECD to assess feasibility, acceptability, and preliminary effects on caregiver mental health, emotion regulation, caregiving behaviors, and family violence in high-risk families with children aged 6-36 months in comparison with control families receiving standard care.
METHODS: We will recruit and enroll CHWs, supervisors, and families with a child aged 6-36 months from community health clinics in Sierra Leone. CHWs and supervisors will participate in 1 problem analysis focus group and 2 user interface/user experience cycles to provide feedback on mHealth tool prototypes. Families will be randomized to mHealth-supported FSI-ECD or standard maternal and child health services. We will collect quantitative data on caregiver mental health, emotion regulation, caregiving behaviors, and family functioning at baseline, postintervention, and 3-month follow up. We will use a mixed methods approach to explore feasibility and acceptability of mHealth tools and the FSI-ECD. Mixed effects linear modeling will assess FSI-ECD effects on caregiver outcomes. Cost-effectiveness analysis will estimate costs across FSI-ECD versus standard care.
RESULTS: Funding for this study was received from the National Institutes of Mental Health on August 17, 2020. Institutional Review Board approval was received on September 4, 2020. Data collection is projected to begin on December 15, 2020.
CONCLUSIONS: This study will provide important data on the feasibility, acceptability, and preliminary efficacy of mHealth-supported delivery of an evidence-based family home-visiting intervention in a postconflict LMIC. TRIAL REGISTRATION: ClinicalTrials.gov NCT04481399; https://clinicaltrials.gov/ct2/show/NCT04481399. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/25443. ©Alethea Desrosiers, Carolyn Schafer, Rebecca Esliker, Musu Jambai, Theresa Betancourt. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 02.02.2021.

Entities:  

Keywords:  caregiver mental health; community health workers; early childhood development; family functioning; mHealth

Year:  2021        PMID: 33528371     DOI: 10.2196/25443

Source DB:  PubMed          Journal:  JMIR Res Protoc        ISSN: 1929-0748


  2 in total

Review 1.  Measurement and assessment of fidelity and competence in nonspecialist-delivered, evidence-based behavioral and mental health interventions: A systematic review.

Authors:  Laura Bond; Erik Simmons; Erika L Sabbath
Journal:  SSM Popul Health       Date:  2022-10-04

2.  Psychometric performance of the Mental Health Implementation Science Tools (mhIST) across six low- and middle-income countries.

Authors:  Laura K Murray; Emily E Haroz; Luke R Aldridge; Christopher G Kemp; Judith K Bass; Kristen Danforth; Jeremy C Kane; Syed U Hamdani; Lisa A Marsch; José M Uribe-Restrepo; Amanda J Nguyen; Paul A Bolton
Journal:  Implement Sci Commun       Date:  2022-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.